ARTICLE

2017 | AIRTICLE

3-V Biosciences and Mosaic Laboratories (Referenced in Acknoledgements)

O Farrell M, Heuer T, Grimmer K, Waszczuk J, Fridlip M, Ventura R, Caudia Rubio, Julie Lai, Arjun Panda, Doug Buckley, William McCulloch, George kemble.

FASN inhibitor TVB-2640 Shows Parmacodyanmic effect and evidence of clinical activity in KRAS mutant NSCLC Patients in phase 1 Study. AACR Meeting